{
  "ticker": "ATX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02977873",
  "id": "02977873",
  "pages": 22,
  "price_sensitive": false,
  "date": "20250807",
  "time": "0934",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250807/pdf/06mmjj4m2rrkpx.pdf",
  "summary": "No material information identified.  \n\n**Reasons:**  \n- The document is a presentation summary for a Biotech Summit with no new material data (financial, regulatory, or operational) beyond previously disclosed clinical trial updates.  \n- No actionable capital markets elements (e.g., funding, timelines, material clinical results) are provided.  \n- Forward-looking statements are generic and non-binding.  \n\n*Note:* Clinical trial data cited (e.g., PFS of 7.6 months) appears consistent with prior disclosures; no incremental updates.",
  "usage": {
    "prompt_tokens": 4703,
    "completion_tokens": 108,
    "total_tokens": 4811,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-06T23:52:52.941360"
}